nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—TUBB4B—Docetaxel—pancreatic cancer	0.244	0.285	CbGbCtD
Albendazole—CYP1A1—Dacarbazine—pancreatic cancer	0.0995	0.116	CbGbCtD
Albendazole—CYP1A1—Tamoxifen—pancreatic cancer	0.0791	0.0922	CbGbCtD
Albendazole—CYP1A1—Erlotinib—pancreatic cancer	0.0673	0.0784	CbGbCtD
Albendazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0444	0.0518	CbGbCtD
Albendazole—CYP1A2—Tamoxifen—pancreatic cancer	0.0354	0.0412	CbGbCtD
Albendazole—ABCB1—Tamoxifen—pancreatic cancer	0.0309	0.036	CbGbCtD
Albendazole—CYP1A2—Erlotinib—pancreatic cancer	0.0301	0.035	CbGbCtD
Albendazole—ABCB1—Gemcitabine—pancreatic cancer	0.0266	0.031	CbGbCtD
Albendazole—ABCB1—Erlotinib—pancreatic cancer	0.0263	0.0306	CbGbCtD
Albendazole—CYP1A2—Fluorouracil—pancreatic cancer	0.0261	0.0303	CbGbCtD
Albendazole—ABCB1—Irinotecan—pancreatic cancer	0.0237	0.0276	CbGbCtD
Albendazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0185	0.0216	CbGbCtD
Albendazole—ABCB1—Docetaxel—pancreatic cancer	0.0174	0.0203	CbGbCtD
Albendazole—ABCB1—Sunitinib—pancreatic cancer	0.0173	0.0202	CbGbCtD
Albendazole—CYP3A4—Erlotinib—pancreatic cancer	0.0157	0.0183	CbGbCtD
Albendazole—CYP3A4—Irinotecan—pancreatic cancer	0.0142	0.0166	CbGbCtD
Albendazole—ABCB1—Doxorubicin—pancreatic cancer	0.013	0.0151	CbGbCtD
Albendazole—CYP3A4—Docetaxel—pancreatic cancer	0.0104	0.0121	CbGbCtD
Albendazole—CYP3A4—Sunitinib—pancreatic cancer	0.0104	0.0121	CbGbCtD
Albendazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00777	0.00905	CbGbCtD
Albendazole—Alopecia reversible—Gemcitabine—pancreatic cancer	0.00647	0.054	CcSEcCtD
Albendazole—TUBA1A—Zalcitabine—Gemcitabine—pancreatic cancer	0.00523	0.826	CbGdCrCtD
Albendazole—Alopecia reversible—Epirubicin—pancreatic cancer	0.0031	0.0259	CcSEcCtD
Albendazole—Alopecia reversible—Doxorubicin—pancreatic cancer	0.00287	0.0239	CcSEcCtD
Albendazole—Renal failure acute—Erlotinib—pancreatic cancer	0.00166	0.0139	CcSEcCtD
Albendazole—Renal failure acute—Sunitinib—pancreatic cancer	0.00144	0.012	CcSEcCtD
Albendazole—Liver function test abnormal—Tamoxifen—pancreatic cancer	0.00143	0.012	CcSEcCtD
Albendazole—Pancytopenia—Tamoxifen—pancreatic cancer	0.00127	0.0106	CcSEcCtD
Albendazole—Neutropenia—Tamoxifen—pancreatic cancer	0.00125	0.0105	CcSEcCtD
Albendazole—Neutropenia—Erlotinib—pancreatic cancer	0.00124	0.0104	CcSEcCtD
Albendazole—Liver function test abnormal—Sunitinib—pancreatic cancer	0.00123	0.0102	CcSEcCtD
Albendazole—Renal failure acute—Irinotecan—pancreatic cancer	0.00119	0.0099	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00119	0.0099	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00117	0.00979	CcSEcCtD
Albendazole—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.00112	0.00934	CcSEcCtD
Albendazole—TUBA1A—Azacitidine—Gemcitabine—pancreatic cancer	0.0011	0.174	CbGdCrCtD
Albendazole—Pancytopenia—Sunitinib—pancreatic cancer	0.00109	0.00911	CcSEcCtD
Albendazole—Neutropenia—Sunitinib—pancreatic cancer	0.00107	0.00897	CcSEcCtD
Albendazole—Hepatitis—Tamoxifen—pancreatic cancer	0.00107	0.00896	CcSEcCtD
Albendazole—Hepatitis—Erlotinib—pancreatic cancer	0.00106	0.00887	CcSEcCtD
Albendazole—Urinary tract disorder—Erlotinib—pancreatic cancer	0.00105	0.00876	CcSEcCtD
Albendazole—Urethral disorder—Erlotinib—pancreatic cancer	0.00104	0.00869	CcSEcCtD
Albendazole—TUBA1A—gall bladder—pancreatic cancer	0.00103	0.237	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00102	0.00848	CcSEcCtD
Albendazole—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00101	0.00847	CcSEcCtD
Albendazole—Erythema multiforme—Erlotinib—pancreatic cancer	0.001	0.00838	CcSEcCtD
Albendazole—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.000984	0.00822	CcSEcCtD
Albendazole—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000968	0.00809	CcSEcCtD
Albendazole—Alopecia—Tamoxifen—pancreatic cancer	0.000948	0.00792	CcSEcCtD
Albendazole—Alopecia—Erlotinib—pancreatic cancer	0.000938	0.00784	CcSEcCtD
Albendazole—Hepatitis—Sunitinib—pancreatic cancer	0.000919	0.00768	CcSEcCtD
Albendazole—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000908	0.00758	CcSEcCtD
Albendazole—Urethral disorder—Sunitinib—pancreatic cancer	0.000901	0.00752	CcSEcCtD
Albendazole—Neutropenia—Irinotecan—pancreatic cancer	0.000885	0.00739	CcSEcCtD
Albendazole—Pancytopenia—Gemcitabine—pancreatic cancer	0.000875	0.00731	CcSEcCtD
Albendazole—Erythema multiforme—Sunitinib—pancreatic cancer	0.000869	0.00726	CcSEcCtD
Albendazole—Neutropenia—Gemcitabine—pancreatic cancer	0.000862	0.0072	CcSEcCtD
Albendazole—Pancytopenia—Fluorouracil—pancreatic cancer	0.00086	0.00719	CcSEcCtD
Albendazole—Leukopenia—Tamoxifen—pancreatic cancer	0.000836	0.00698	CcSEcCtD
Albendazole—Immune system disorder—Sunitinib—pancreatic cancer	0.00083	0.00693	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000815	0.0068	CcSEcCtD
Albendazole—Alopecia—Sunitinib—pancreatic cancer	0.000812	0.00678	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000782	0.00653	CcSEcCtD
Albendazole—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000777	0.00649	CcSEcCtD
Albendazole—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000767	0.0064	CcSEcCtD
Albendazole—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000754	0.0063	CcSEcCtD
Albendazole—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000747	0.00623	CcSEcCtD
Albendazole—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000739	0.00617	CcSEcCtD
Albendazole—Skin disorder—Erlotinib—pancreatic cancer	0.000733	0.00612	CcSEcCtD
Albendazole—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000728	0.00608	CcSEcCtD
Albendazole—Urethral disorder—Gemcitabine—pancreatic cancer	0.000723	0.00604	CcSEcCtD
Albendazole—Leukopenia—Sunitinib—pancreatic cancer	0.000716	0.00598	CcSEcCtD
Albendazole—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000699	0.00583	CcSEcCtD
Albendazole—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000697	0.00582	CcSEcCtD
Albendazole—Immune system disorder—Irinotecan—pancreatic cancer	0.000684	0.00571	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000677	0.00565	CcSEcCtD
Albendazole—TUBA1A—islet of Langerhans—pancreatic cancer	0.000675	0.156	CbGeAlD
Albendazole—Alopecia—Irinotecan—pancreatic cancer	0.000669	0.00559	CcSEcCtD
Albendazole—Immune system disorder—Gemcitabine—pancreatic cancer	0.000666	0.00556	CcSEcCtD
Albendazole—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00066	0.00551	CcSEcCtD
Albendazole—Alopecia—Gemcitabine—pancreatic cancer	0.000652	0.00544	CcSEcCtD
Albendazole—Alopecia—Fluorouracil—pancreatic cancer	0.000641	0.00535	CcSEcCtD
Albendazole—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000639	0.00534	CcSEcCtD
Albendazole—Skin disorder—Sunitinib—pancreatic cancer	0.000634	0.0053	CcSEcCtD
Albendazole—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000624	0.00521	CcSEcCtD
Albendazole—Pancytopenia—Docetaxel—pancreatic cancer	0.000621	0.00519	CcSEcCtD
Albendazole—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000617	0.00515	CcSEcCtD
Albendazole—Neutropenia—Docetaxel—pancreatic cancer	0.000612	0.00511	CcSEcCtD
Albendazole—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000611	0.0051	CcSEcCtD
Albendazole—Urticaria—Tamoxifen—pancreatic cancer	0.000606	0.00506	CcSEcCtD
Albendazole—Abdominal pain—Tamoxifen—pancreatic cancer	0.000603	0.00503	CcSEcCtD
Albendazole—Abdominal pain—Erlotinib—pancreatic cancer	0.000596	0.00498	CcSEcCtD
Albendazole—Body temperature increased—Erlotinib—pancreatic cancer	0.000596	0.00498	CcSEcCtD
Albendazole—Vertigo—Irinotecan—pancreatic cancer	0.000592	0.00495	CcSEcCtD
Albendazole—Leukopenia—Irinotecan—pancreatic cancer	0.00059	0.00493	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000578	0.00483	CcSEcCtD
Albendazole—Leukopenia—Gemcitabine—pancreatic cancer	0.000575	0.0048	CcSEcCtD
Albendazole—Leukopenia—Fluorouracil—pancreatic cancer	0.000565	0.00472	CcSEcCtD
Albendazole—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000562	0.00469	CcSEcCtD
Albendazole—Renal failure acute—Epirubicin—pancreatic cancer	0.000553	0.00462	CcSEcCtD
Albendazole—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000551	0.0046	CcSEcCtD
Albendazole—Agranulocytosis—Docetaxel—pancreatic cancer	0.000544	0.00454	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000543	0.00453	CcSEcCtD
Albendazole—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000534	0.00446	CcSEcCtD
Albendazole—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000527	0.0044	CcSEcCtD
Albendazole—Hepatitis—Docetaxel—pancreatic cancer	0.000523	0.00437	CcSEcCtD
Albendazole—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000517	0.00432	CcSEcCtD
Albendazole—Body temperature increased—Sunitinib—pancreatic cancer	0.000516	0.00431	CcSEcCtD
Albendazole—Abdominal pain—Sunitinib—pancreatic cancer	0.000516	0.00431	CcSEcCtD
Albendazole—Urethral disorder—Docetaxel—pancreatic cancer	0.000513	0.00428	CcSEcCtD
Albendazole—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000513	0.00428	CcSEcCtD
Albendazole—Renal failure acute—Doxorubicin—pancreatic cancer	0.000511	0.00427	CcSEcCtD
Albendazole—Skin disorder—Gemcitabine—pancreatic cancer	0.000509	0.00425	CcSEcCtD
Albendazole—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000504	0.00421	CcSEcCtD
Albendazole—Dizziness—Tamoxifen—pancreatic cancer	0.000504	0.00421	CcSEcCtD
Albendazole—Dizziness—Erlotinib—pancreatic cancer	0.000499	0.00417	CcSEcCtD
Albendazole—Erythema multiforme—Docetaxel—pancreatic cancer	0.000495	0.00413	CcSEcCtD
Albendazole—Vomiting—Tamoxifen—pancreatic cancer	0.000485	0.00405	CcSEcCtD
Albendazole—Hypersensitivity—Sunitinib—pancreatic cancer	0.000481	0.00402	CcSEcCtD
Albendazole—Rash—Tamoxifen—pancreatic cancer	0.000481	0.00401	CcSEcCtD
Albendazole—Dermatitis—Tamoxifen—pancreatic cancer	0.00048	0.00401	CcSEcCtD
Albendazole—Vomiting—Erlotinib—pancreatic cancer	0.00048	0.00401	CcSEcCtD
Albendazole—Headache—Tamoxifen—pancreatic cancer	0.000478	0.00399	CcSEcCtD
Albendazole—Rash—Erlotinib—pancreatic cancer	0.000476	0.00397	CcSEcCtD
Albendazole—Dermatitis—Erlotinib—pancreatic cancer	0.000475	0.00397	CcSEcCtD
Albendazole—TUBA1A—pancreas—pancreatic cancer	0.000475	0.109	CbGeAlD
Albendazole—Immune system disorder—Docetaxel—pancreatic cancer	0.000473	0.00395	CcSEcCtD
Albendazole—Headache—Erlotinib—pancreatic cancer	0.000473	0.00395	CcSEcCtD
Albendazole—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000471	0.00393	CcSEcCtD
Albendazole—Alopecia—Docetaxel—pancreatic cancer	0.000463	0.00386	CcSEcCtD
Albendazole—Nausea—Tamoxifen—pancreatic cancer	0.000453	0.00378	CcSEcCtD
Albendazole—TUBB4B—islet of Langerhans—pancreatic cancer	0.00045	0.104	CbGeAlD
Albendazole—Nausea—Erlotinib—pancreatic cancer	0.000448	0.00374	CcSEcCtD
Albendazole—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00044	0.00367	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000436	0.00364	CcSEcCtD
Albendazole—Dizziness—Sunitinib—pancreatic cancer	0.000432	0.00361	CcSEcCtD
Albendazole—Abdominal pain—Irinotecan—pancreatic cancer	0.000425	0.00355	CcSEcCtD
Albendazole—Body temperature increased—Irinotecan—pancreatic cancer	0.000425	0.00355	CcSEcCtD
Albendazole—Pancytopenia—Epirubicin—pancreatic cancer	0.000419	0.0035	CcSEcCtD
Albendazole—Vomiting—Sunitinib—pancreatic cancer	0.000415	0.00347	CcSEcCtD
Albendazole—Body temperature increased—Gemcitabine—pancreatic cancer	0.000414	0.00346	CcSEcCtD
Albendazole—Neutropenia—Epirubicin—pancreatic cancer	0.000412	0.00344	CcSEcCtD
Albendazole—Rash—Sunitinib—pancreatic cancer	0.000412	0.00344	CcSEcCtD
Albendazole—Dermatitis—Sunitinib—pancreatic cancer	0.000411	0.00344	CcSEcCtD
Albendazole—Urticaria—Fluorouracil—pancreatic cancer	0.000409	0.00342	CcSEcCtD
Albendazole—Headache—Sunitinib—pancreatic cancer	0.000409	0.00342	CcSEcCtD
Albendazole—Leukopenia—Docetaxel—pancreatic cancer	0.000408	0.00341	CcSEcCtD
Albendazole—Body temperature increased—Fluorouracil—pancreatic cancer	0.000407	0.0034	CcSEcCtD
Albendazole—TUBA1A—digestive system—pancreatic cancer	0.000406	0.0934	CbGeAlD
Albendazole—Hypersensitivity—Irinotecan—pancreatic cancer	0.000396	0.00331	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00039	0.00326	CcSEcCtD
Albendazole—Nausea—Sunitinib—pancreatic cancer	0.000388	0.00324	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—pancreatic cancer	0.000388	0.00324	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000385	0.00322	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—pancreatic cancer	0.000382	0.00319	CcSEcCtD
Albendazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00038	0.00317	CcSEcCtD
Albendazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000372	0.00311	CcSEcCtD
Albendazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000367	0.00306	CcSEcCtD
Albendazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000364	0.00304	CcSEcCtD
Albendazole—Skin disorder—Docetaxel—pancreatic cancer	0.000361	0.00302	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000361	0.00301	CcSEcCtD
Albendazole—Dizziness—Irinotecan—pancreatic cancer	0.000356	0.00297	CcSEcCtD
Albendazole—Hepatitis—Epirubicin—pancreatic cancer	0.000353	0.00295	CcSEcCtD
Albendazole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000349	0.00291	CcSEcCtD
Albendazole—Urethral disorder—Epirubicin—pancreatic cancer	0.000346	0.00289	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000344	0.00287	CcSEcCtD
Albendazole—Vomiting—Irinotecan—pancreatic cancer	0.000342	0.00286	CcSEcCtD
Albendazole—Dizziness—Fluorouracil—pancreatic cancer	0.000341	0.00285	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00034	0.00284	CcSEcCtD
Albendazole—Rash—Irinotecan—pancreatic cancer	0.000339	0.00283	CcSEcCtD
Albendazole—Dermatitis—Irinotecan—pancreatic cancer	0.000339	0.00283	CcSEcCtD
Albendazole—Headache—Irinotecan—pancreatic cancer	0.000337	0.00281	CcSEcCtD
Albendazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000334	0.00279	CcSEcCtD
Albendazole—Vomiting—Gemcitabine—pancreatic cancer	0.000333	0.00278	CcSEcCtD
Albendazole—Rash—Gemcitabine—pancreatic cancer	0.00033	0.00276	CcSEcCtD
Albendazole—Dermatitis—Gemcitabine—pancreatic cancer	0.00033	0.00276	CcSEcCtD
Albendazole—Headache—Gemcitabine—pancreatic cancer	0.000328	0.00274	CcSEcCtD
Albendazole—Vomiting—Fluorouracil—pancreatic cancer	0.000328	0.00274	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000327	0.00273	CcSEcCtD
Albendazole—Rash—Fluorouracil—pancreatic cancer	0.000325	0.00271	CcSEcCtD
Albendazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000325	0.00271	CcSEcCtD
Albendazole—Headache—Fluorouracil—pancreatic cancer	0.000323	0.0027	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000323	0.00269	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—pancreatic cancer	0.00032	0.00267	CcSEcCtD
Albendazole—Nausea—Irinotecan—pancreatic cancer	0.00032	0.00267	CcSEcCtD
Albendazole—Immune system disorder—Epirubicin—pancreatic cancer	0.000319	0.00266	CcSEcCtD
Albendazole—TUBB4B—pancreas—pancreatic cancer	0.000316	0.0729	CbGeAlD
Albendazole—Alopecia—Epirubicin—pancreatic cancer	0.000312	0.00261	CcSEcCtD
Albendazole—Nausea—Gemcitabine—pancreatic cancer	0.000311	0.0026	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000309	0.00258	CcSEcCtD
Albendazole—Nausea—Fluorouracil—pancreatic cancer	0.000306	0.00256	CcSEcCtD
Albendazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000304	0.00254	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—pancreatic cancer	0.000295	0.00246	CcSEcCtD
Albendazole—Abdominal pain—Docetaxel—pancreatic cancer	0.000294	0.00245	CcSEcCtD
Albendazole—Body temperature increased—Docetaxel—pancreatic cancer	0.000294	0.00245	CcSEcCtD
Albendazole—Alopecia—Doxorubicin—pancreatic cancer	0.000289	0.00241	CcSEcCtD
Albendazole—Vertigo—Epirubicin—pancreatic cancer	0.000276	0.00231	CcSEcCtD
Albendazole—Leukopenia—Epirubicin—pancreatic cancer	0.000275	0.0023	CcSEcCtD
Albendazole—Hypersensitivity—Docetaxel—pancreatic cancer	0.000274	0.00229	CcSEcCtD
Albendazole—TUBB4B—digestive system—pancreatic cancer	0.00027	0.0623	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00026	0.00217	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—pancreatic cancer	0.000255	0.00213	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—pancreatic cancer	0.000255	0.00213	CcSEcCtD
Albendazole—Dizziness—Docetaxel—pancreatic cancer	0.000246	0.00205	CcSEcCtD
Albendazole—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000246	0.00205	CcSEcCtD
Albendazole—Skin disorder—Epirubicin—pancreatic cancer	0.000244	0.00203	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00024	0.00201	CcSEcCtD
Albendazole—Vomiting—Docetaxel—pancreatic cancer	0.000236	0.00197	CcSEcCtD
Albendazole—Rash—Docetaxel—pancreatic cancer	0.000234	0.00196	CcSEcCtD
Albendazole—Dermatitis—Docetaxel—pancreatic cancer	0.000234	0.00196	CcSEcCtD
Albendazole—Headache—Docetaxel—pancreatic cancer	0.000233	0.00195	CcSEcCtD
Albendazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000227	0.0019	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—pancreatic cancer	0.000225	0.00188	CcSEcCtD
Albendazole—Nausea—Docetaxel—pancreatic cancer	0.000221	0.00184	CcSEcCtD
Albendazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000205	0.00171	CcSEcCtD
Albendazole—Urticaria—Epirubicin—pancreatic cancer	0.000199	0.00166	CcSEcCtD
Albendazole—Abdominal pain—Epirubicin—pancreatic cancer	0.000198	0.00166	CcSEcCtD
Albendazole—Body temperature increased—Epirubicin—pancreatic cancer	0.000198	0.00166	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00019	0.00158	CcSEcCtD
Albendazole—Hypersensitivity—Epirubicin—pancreatic cancer	0.000185	0.00154	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—pancreatic cancer	0.000184	0.00154	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—pancreatic cancer	0.000183	0.00153	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—pancreatic cancer	0.000183	0.00153	CcSEcCtD
Albendazole—TUBB4B—G2/M Transition—FOXM1—pancreatic cancer	0.000181	0.0166	CbGpPWpGaD
Albendazole—TUBB4B—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	0.000178	0.0164	CbGpPWpGaD
Albendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	0.000177	0.0163	CbGpPWpGaD
Albendazole—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000171	0.00143	CcSEcCtD
Albendazole—Dizziness—Epirubicin—pancreatic cancer	0.000166	0.00139	CcSEcCtD
Albendazole—Vomiting—Epirubicin—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Albendazole—Rash—Epirubicin—pancreatic cancer	0.000158	0.00132	CcSEcCtD
Albendazole—Dermatitis—Epirubicin—pancreatic cancer	0.000158	0.00132	CcSEcCtD
Albendazole—Headache—Epirubicin—pancreatic cancer	0.000157	0.00131	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—pancreatic cancer	0.000153	0.00128	CcSEcCtD
Albendazole—CYP1A2—digestive system—pancreatic cancer	0.000153	0.0354	CbGeAlD
Albendazole—CYP1A1—digestive system—pancreatic cancer	0.000151	0.0349	CbGeAlD
Albendazole—Nausea—Epirubicin—pancreatic cancer	0.000149	0.00124	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—pancreatic cancer	0.000148	0.00123	CcSEcCtD
Albendazole—Rash—Doxorubicin—pancreatic cancer	0.000146	0.00122	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—pancreatic cancer	0.000146	0.00122	CcSEcCtD
Albendazole—Headache—Doxorubicin—pancreatic cancer	0.000145	0.00121	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle—SYCP1—pancreatic cancer	0.000145	0.0133	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—FUT8—pancreatic cancer	0.000142	0.0131	CbGpPWpGaD
Albendazole—TUBA1A—p73 transcription factor network—RB1—pancreatic cancer	0.000141	0.013	CbGpPWpGaD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	0.000138	0.0127	CbGpPWpGaD
Albendazole—Nausea—Doxorubicin—pancreatic cancer	0.000138	0.00115	CcSEcCtD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.000135	0.0124	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.000135	0.0124	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000133	0.0122	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000131	0.0121	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000131	0.0121	CbGpPWpGaD
Albendazole—ABCB1—islet of Langerhans—pancreatic cancer	0.000131	0.0302	CbGeAlD
Albendazole—TUBA1A—Cell Cycle—RBBP8—pancreatic cancer	0.000123	0.0113	CbGpPWpGaD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000113	0.0104	CbGpPWpGaD
Albendazole—CYP3A4—digestive system—pancreatic cancer	0.000111	0.0256	CbGeAlD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000108	0.00997	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000107	0.00983	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000104	0.00953	CbGpPWpGaD
Albendazole—CYP1A1—Oxidative Stress—SOD2—pancreatic cancer	0.000103	0.00946	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—PPP2R5B—pancreatic cancer	9.55e-05	0.00879	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	9.52e-05	0.00876	CbGpPWpGaD
Albendazole—ABCB1—pancreas—pancreatic cancer	9.2e-05	0.0212	CbGeAlD
Albendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—pancreatic cancer	8.78e-05	0.00809	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—PCSK1—pancreatic cancer	8.7e-05	0.00801	CbGpPWpGaD
Albendazole—CYP1A1—Melatonin metabolism and effects—APOE—pancreatic cancer	8.65e-05	0.00796	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—FUT8—pancreatic cancer	8.6e-05	0.00792	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	8.58e-05	0.0079	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	8.58e-05	0.0079	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—FOXM1—pancreatic cancer	8.51e-05	0.00784	CbGpPWpGaD
Albendazole—TUBA1A—p73 transcription factor network—MYC—pancreatic cancer	8.39e-05	0.00772	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	8.36e-05	0.0077	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	8.36e-05	0.0077	CbGpPWpGaD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	8.35e-05	0.00769	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—PPP2R5B—pancreatic cancer	7.96e-05	0.00733	CbGpPWpGaD
Albendazole—ABCB1—digestive system—pancreatic cancer	7.86e-05	0.0181	CbGeAlD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	7.58e-05	0.00698	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—RBBP8—pancreatic cancer	7.42e-05	0.00683	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	7.31e-05	0.00673	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	6.55e-05	0.00603	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	6.45e-05	0.00594	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—PPP2R5B—pancreatic cancer	5.77e-05	0.00531	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	5.75e-05	0.00529	CbGpPWpGaD
Albendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	5.6e-05	0.00516	CbGpPWpGaD
Albendazole—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	5.52e-05	0.00508	CbGpPWpGaD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.3e-05	0.00488	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—PCSK1—pancreatic cancer	5.26e-05	0.00484	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—FOXM1—pancreatic cancer	5.14e-05	0.00473	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	4.99e-05	0.00459	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	4.96e-05	0.00457	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—PPP2R5B—pancreatic cancer	4.81e-05	0.00442	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	4.76e-05	0.00438	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—BRCA2—pancreatic cancer	4.66e-05	0.00429	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	4.66e-05	0.00429	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—GCG—pancreatic cancer	4.57e-05	0.00421	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	4.49e-05	0.00414	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	4.48e-05	0.00412	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TYMS—pancreatic cancer	4.44e-05	0.00408	CbGpPWpGaD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.23e-05	0.00389	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	4.1e-05	0.00377	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.09e-05	0.00377	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	4.04e-05	0.00372	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TERT—pancreatic cancer	3.86e-05	0.00356	CbGpPWpGaD
Albendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	3.83e-05	0.00353	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	3.83e-05	0.00353	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	3.67e-05	0.00337	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—RB1—pancreatic cancer	3.36e-05	0.0031	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	3.35e-05	0.00309	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	3.31e-05	0.00305	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	3.31e-05	0.00305	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	3.29e-05	0.00303	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	3.26e-05	0.00301	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	3.23e-05	0.00297	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	3.19e-05	0.00293	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	3.18e-05	0.00293	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	3.01e-05	0.00277	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—RB1—pancreatic cancer	3.01e-05	0.00277	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—TYMS—pancreatic cancer	3e-05	0.00276	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	2.97e-05	0.00274	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	2.97e-05	0.00273	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	2.96e-05	0.00273	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	2.96e-05	0.00272	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	2.9e-05	0.00267	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	2.9e-05	0.00267	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—BRCA2—pancreatic cancer	2.82e-05	0.00259	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	2.77e-05	0.00255	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	2.77e-05	0.00255	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—GCG—pancreatic cancer	2.76e-05	0.00254	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	2.74e-05	0.00253	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TYMS—pancreatic cancer	2.68e-05	0.00247	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN2A—pancreatic cancer	2.64e-05	0.00243	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	2.61e-05	0.00241	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	2.6e-05	0.00239	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—PPARG—pancreatic cancer	2.59e-05	0.00239	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	2.55e-05	0.00235	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	2.54e-05	0.00234	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	2.5e-05	0.0023	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	2.44e-05	0.00225	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MMP2—pancreatic cancer	2.41e-05	0.00221	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TERT—pancreatic cancer	2.33e-05	0.00215	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.33e-05	0.00215	CbGpPWpGaD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	2.26e-05	0.00208	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CCND1—pancreatic cancer	2.23e-05	0.00206	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.19e-05	0.00201	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	2.11e-05	0.00195	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	2.11e-05	0.00195	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	2.06e-05	0.0019	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	2.06e-05	0.00189	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	2.03e-05	0.00187	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—RB1—pancreatic cancer	2.03e-05	0.00187	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MYC—pancreatic cancer	2e-05	0.00184	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CXCL8—pancreatic cancer	2e-05	0.00184	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.98e-05	0.00182	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	1.97e-05	0.00181	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	1.93e-05	0.00178	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.91e-05	0.00176	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	1.89e-05	0.00174	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	1.89e-05	0.00174	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.88e-05	0.00173	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	1.85e-05	0.0017	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	1.85e-05	0.0017	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CTNNB1—pancreatic cancer	1.84e-05	0.0017	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—RB1—pancreatic cancer	1.82e-05	0.00167	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MYC—pancreatic cancer	1.79e-05	0.00165	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.79e-05	0.00164	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	1.76e-05	0.00162	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	1.76e-05	0.00162	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	1.75e-05	0.00161	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	1.75e-05	0.00161	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	1.67e-05	0.00154	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—pancreatic cancer	1.6e-05	0.00147	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	1.54e-05	0.00141	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.51e-05	0.00139	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	1.49e-05	0.00137	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—pancreatic cancer	1.47e-05	0.00135	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP2—pancreatic cancer	1.45e-05	0.00134	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.43e-05	0.00132	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.43e-05	0.00131	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.36e-05	0.00126	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND1—pancreatic cancer	1.35e-05	0.00124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PRSS1—pancreatic cancer	1.28e-05	0.00118	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.24e-05	0.00114	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.23e-05	0.00113	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.21e-05	0.00111	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CXCL8—pancreatic cancer	1.21e-05	0.00111	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CTNNB1—pancreatic cancer	1.11e-05	0.00102	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ARG2—pancreatic cancer	1.11e-05	0.00102	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—pancreatic cancer	1.08e-05	0.000996	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.05e-05	0.000965	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.02e-05	0.00094	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	9.73e-06	0.000895	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TYMP—pancreatic cancer	9.69e-06	0.000892	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	9.47e-06	0.000872	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	9.38e-06	0.000863	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	9.14e-06	0.000841	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—pancreatic cancer	8.88e-06	0.000818	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ARG2—pancreatic cancer	8.85e-06	0.000815	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	8.48e-06	0.00078	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	8.25e-06	0.00076	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PRSS1—pancreatic cancer	8.15e-06	0.00075	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8e-06	0.000736	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GLP1R—pancreatic cancer	7.81e-06	0.000719	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TYMP—pancreatic cancer	7.74e-06	0.000712	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—DPYD—pancreatic cancer	7.68e-06	0.000707	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	7.59e-06	0.000699	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	7.58e-06	0.000697	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	7.43e-06	0.000684	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	7.29e-06	0.000671	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.22e-06	0.000664	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.07e-06	0.000651	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ARG2—pancreatic cancer	7.07e-06	0.000651	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.02e-06	0.000646	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.96e-06	0.000641	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.45e-06	0.000593	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.34e-06	0.000584	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	6.29e-06	0.000579	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GLP1R—pancreatic cancer	6.24e-06	0.000574	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.24e-06	0.000574	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TYMP—pancreatic cancer	6.18e-06	0.000569	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—DPYD—pancreatic cancer	6.14e-06	0.000565	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A2—pancreatic cancer	5.82e-06	0.000536	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CD44—pancreatic cancer	5.65e-06	0.00052	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.53e-06	0.000509	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.48e-06	0.000504	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.46e-06	0.000502	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GCG—pancreatic cancer	5.41e-06	0.000498	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.27e-06	0.000485	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.1e-06	0.000469	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—STK11—pancreatic cancer	5.09e-06	0.000469	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.98e-06	0.000458	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.9e-06	0.000451	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.78e-06	0.00044	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.77e-06	0.000439	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.65e-06	0.000428	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.6e-06	0.000424	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CD44—pancreatic cancer	4.51e-06	0.000415	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.44e-06	0.000409	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TYMS—pancreatic cancer	4.38e-06	0.000403	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCG—pancreatic cancer	4.32e-06	0.000398	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—STK11—pancreatic cancer	4.07e-06	0.000374	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.04e-06	0.000372	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.84e-06	0.000354	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.78e-06	0.000348	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CD44—pancreatic cancer	3.6e-06	0.000331	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.59e-06	0.00033	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOE—pancreatic cancer	3.56e-06	0.000328	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.53e-06	0.000325	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TYMS—pancreatic cancer	3.5e-06	0.000322	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.49e-06	0.000322	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCG—pancreatic cancer	3.45e-06	0.000318	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.37e-06	0.00031	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—STK11—pancreatic cancer	3.25e-06	0.000299	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	3.21e-06	0.000296	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—pancreatic cancer	3.1e-06	0.000286	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.05e-06	0.00028	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOE—pancreatic cancer	2.84e-06	0.000262	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	2.83e-06	0.00026	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.79e-06	0.000257	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CD44—pancreatic cancer	2.78e-06	0.000256	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCG—pancreatic cancer	2.66e-06	0.000245	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.57e-06	0.000236	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—STK11—pancreatic cancer	2.5e-06	0.000231	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—pancreatic cancer	2.48e-06	0.000228	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	2.46e-06	0.000227	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—pancreatic cancer	2.44e-06	0.000225	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOE—pancreatic cancer	2.27e-06	0.000209	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.26e-06	0.000208	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.15e-06	0.000198	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.15e-06	0.000198	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.13e-06	0.000196	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.05e-06	0.000189	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.98e-06	0.000182	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.97e-06	0.000181	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.95e-06	0.000179	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.8e-06	0.000166	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOE—pancreatic cancer	1.75e-06	0.000161	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—pancreatic cancer	1.7e-06	0.000156	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.58e-06	0.000146	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.57e-06	0.000145	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.56e-06	0.000143	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.53e-06	0.00014	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.5e-06	0.000138	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.39e-06	0.000128	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.36e-06	0.000125	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.23e-06	0.000113	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.21e-06	0.000112	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.2e-06	0.000111	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.2e-06	0.00011	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.05e-06	9.64e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—pancreatic cancer	9.79e-07	9.02e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	9.57e-07	8.81e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—pancreatic cancer	7.82e-07	7.2e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.39e-07	6.8e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.03e-07	5.55e-05	CbGpPWpGaD
